The loss of MLH1 in sporadic cancers was due to epigenetic silencing caused by promoter methylation in 65 out of 66 cases.
Comprobouse que a perda de MLH1 en cancros esporádicos debíase a silenciamento epixenetico causado por metilación do promotor en 65 de 66 casos.